Can Enhanced Acute-Phase Treatment of Depression Improve Long-Term Outcomes? A Report of Randomized Trials in Primary Care
American Journal of PsychiatryPublished 1 April 1999
Elizabeth Lin, Gregory E. Simon, Wayne Katon, Joan Russo, Michael Von Korff, Terry Bush
Citations93
SJR quartileQ1
SJR score5.27
SNIP3.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Even though enhanced acute-phase treatment of depression in primary care resulted in better treatment adherence and better clinical outcomes at 4 and 7 months, these improvements failed to persist over the following year.
Abstract
Even though enhanced acute-phase treatment of depression in primary care resulted in better treatment adherence and better clinical outcomes at 4 and 7 months, these improvements failed to persist over the following year. Continued enhancement of depression treatment may be needed to ensure better long-term results.
Keywords
PsychologyMedicine
JAMACollaborative Management to Achieve Treatment Guidelines
1,395 Citations1995Wayne Katon
A multifaceted intervention consisting of collaborative management by the primary care physician and a consulting psychiatrist, intensive patient education, and surveillance of continued refills of antidepressant medication improved adherence to antidepressant regimens in patients with major and with minor depression and resulted in more favorable depressive outcomes.
Archives of General PsychiatryThree-Year Outcomes for Maintenance Therapies in Recurrent Depression
1,309 Citations1990David J. Kupfer
It is concluded that active imipramine treatment is an effective means of preventing recurrence beyond 3 years and that patients with previous episodes less than 2 1/2 years apart, therefore, merit continued prophylaxis for at least 5 years.
Journal of Clinical EpidemiologyA chronic disease score from automated pharmacy data
965 Citations1992Michael Von Korff, Edward H. Wagner +1 more
It is concluded that scoring automated pharmacy data can provide a stable measure of chronic disease status that, after controlling for health care utilization, is associated with physician-rated disease severity, patient-rated health status, and predicts subsequent mortality and hospitalization rates.
Psychiatry ResearchThe inventory for depressive symptomatology (IDS): Preliminary findings
915 Citations1986A. John Rush, Donna E. Giles +4 more
The Inventory for Depressive Symptomatology appears applicable to both inpatients and outpatients with endogenous, atypical, and nonendogenous major depression, and may have utility with dysthymics.
Archives of General PsychiatryA Multifaceted Intervention to Improve Treatment of Depression in Primary Care
850 Citations1996Wayne Katon
Archives of General PsychiatryTreating Major Depression in Primary Care Practice
433 Citations1996Herbert C. Schulberg
Severity of depressive symptoms was reduced more rapidly and more effectively among patients randomized to pharmacotherapy or psychotherapy than among patients assigned to a physician's usual care.
JAMACollaborative management to achieve treatment guidelines. Impact on depression in primary care
375 Citations1995Wayne Katon
Archives of Family MedicineRelapse of Depression in Primary Care: Rate and Clinical Predictors
151 Citations1998Elizabeth Lin
The relapse rate among primary care patients treated for depression approached that of specialty samples, with more than one third reporting relapse in 1 year.